[HTML][HTML] Consensus report from the 7th international forum for liver magnetic resonance imaging

EM Merkle, CJ Zech, C Bartolozzi, MR Bashir… - European …, 2016 - Springer
Objectives Liver-specific MRI is a fast-growing field, with technological and protocol
advancements providing more robust imaging and allowing a greater depth of information …

EASL Clinical Practice Guidelines on the management of benign liver tumours

European Association for the Study of the Liver - Journal of hepatology, 2016 - Elsevier
Benign liver tumours are a heterogeneous group of lesions with different cellular origins, as
summarized by an international panel of experts sponsored by the World Congress of …

The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis

CH Suh, KW Kim, GY Kim, YM Shin, PN Kim… - European radiology, 2015 - Springer
Objective We aimed to systematically review the gadoxetic acid-enhanced magnetic
resonance imaging (Gd-EOB-DTPA-MRI) findings of focal nodular hyperplasia (FNH) and its …

Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to …

I Joo, JM Lee, DH Lee, JH Jeon, JK Han, BI Choi - European radiology, 2015 - Springer
Objectives To determine which dynamic phase (s) of gadoxetic acid-enhanced MRI is most
appropriate to assess “washout” in the noninvasive diagnosis of hepatocellular carcinoma …

LI-RADS Version 2017 versus Version 2018: diagnosis of hepatocellular carcinoma on gadoxetate disodium–enhanced MRI

SM Lee, JM Lee, SJ Ahn, HJ Kang, HK Yang, JH Yoon - Radiology, 2019 - pubs.rsna.org
Background Few studies have reported on the diagnostic performance of Liver Imaging
Reporting and Data System (LI-RADS) LR-5 or LR-5 V in the diagnosis of hepatocellular …

Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid–enhanced MR imaging

A Ba-Ssalamah, C Antunes, D Feier, N Bastati… - Radiology, 2015 - pubs.rsna.org
Purpose To evaluate the diagnostic performance of imaging features of gadoxetic acid–
enhanced magnetic resonance (MR) imaging to differentiate among hepatocellular …

Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of gadoxetic acid-enhanced MRI

I Joo, JM Lee - Liver cancer, 2016 - karger.com
Magnetic resonance imaging (MRI) using gadolinium ethoxybenzyl diethylenetriamine
pentaacetic acid (Gd-EOB-DPTA), or gadoxetic acid for short, is a hepatocyte-specific …

[HTML][HTML] HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI

TA Auer, T Walter-Rittel, D Geisel, W Schöning… - BMC Medical …, 2021 - Springer
Background Recent studies provide evidence that hepatocellular adenomas (HCAs)
frequently take up gadoxetic acid (Gd-EOB) during the hepatobiliary phase (HBP). The …

Evaluation of transient motion during gadoxetic acid–enhanced multiphasic liver magnetic resonance imaging using free-breathing golden-angle radial sparse …

JH Yoon, JM Lee, MH Yu, BY Hur, R Grimm… - Investigative …, 2018 - journals.lww.com
Objectives The aims of this study were to observe the pattern of transient motion after
gadoxetic acid administration including incidence, onset, and duration, and to evaluate the …

Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience

C Grieser, IG Steffen, IB Kramme, H Bläker, E Kilic… - European …, 2014 - Springer
Objectives Evaluation of enhancement characteristics of histopathologically confirmed focal
nodular hyperplasias (FNHs) and hepatocellular adenomas (HCAs) with gadoxetic acid …